KLOOG; Yoel
Patent Applications and Registrations
Patent applications and USPTO patent grants for KLOOG; Yoel.The latest application filed is for "drug-eluting medical devices".
- KLOOG; Yoel - Herzlia IL
- Kloog; Yoel - Herzliya IL
- Kloog; Yoel - Tel Aviv IL
- Kloog; Yoel - Hertzlyia IL
- Kloog; Yoel - Herzelia IL
| Patent | Date |
|---|---|
| Drug-eluting Medical Devices App 20160082161 - ZILBERMAN; Meital ; et al. | 2016-03-24 |
| Lim Kinase Inhibitors App 20150238466 - Kloog; Yoel ; et al. | 2015-08-27 |
| Treatment Of Lung Cancer App 20140088123 - Kloog; Yoel ; et al. | 2014-03-27 |
| Use Of Fts And Analogs To Treat Non-autoimmune-allergic And Non-allergic Inflammatory Conditions App 20130123365 - Mekori; Yoseph A. ; et al. | 2013-05-16 |
| Treatment Of Delayed Cutaneous Hypersensitivity Conditions With S-farnesylthiosalicylic Acid And Analogs Thereof App 20130116326 - Mekori; Yoseph A. ; et al. | 2013-05-09 |
| Treatment Of Multiple Sclerosis App 20130035390 - Kloog; Yoel ; et al. | 2013-02-07 |
| Alkoxyalkyl S-prenylthiosalicylates for treatment of cancer Grant 8,338,481 - Kloog , et al. December 25, 2 | 2012-12-25 |
| Treatment Of Lung Cancer App 20120294957 - Kloog; Yoel ; et al. | 2012-11-22 |
| Cancer treatment using FTS and 2-deoxyglucose Grant 8,278,349 - Kloog , et al. October 2, 2 | 2012-10-02 |
| Treatment of ovarian cancer Grant 8,268,889 - Kloog , et al. September 18, 2 | 2012-09-18 |
| Treatment of lung cancer Grant 8,232,253 - Kloog , et al. July 31, 2 | 2012-07-31 |
| Use Of Fts For The Treatment Of Myocardial Ischemia/reperfusion Injury App 20110130369 - Kloog; Yoel ; et al. | 2011-06-02 |
| Drug-eluting Medical Devices App 20110091515 - Zilberman; Meital ; et al. | 2011-04-21 |
| Treatment Of Neurofibromatosis App 20110046223 - Kloog; Yoel ; et al. | 2011-02-24 |
| Alkoxyalkyl S-prenylthiosalicylates For Treatment Of Cancer App 20100189781 - Kloog; Yoel ; et al. | 2010-07-29 |
| Treatment Of Myocarditis Using Fts App 20100144873 - Kloog; Yoel ; et al. | 2010-06-10 |
| Treatment Of Lung Cancer App 20100136138 - Kloog; Yoel ; et al. | 2010-06-03 |
| Treatment Of Hematological Malignancies With Fts And A Bcr-abl Tyrosine Kinase Inhibitor App 20090298843 - Kloog; Yoel ; et al. | 2009-12-03 |
| Cancer Treatment Using FTS and 2-Deoxyglucose App 20090286870 - Kloog; Yoel ; et al. | 2009-11-19 |
| Treatment of Ovarian Cancer App 20090226539 - Kloog; Yoel ; et al. | 2009-09-10 |
| Farnesyl derivatives and pharmaceutical compositions containing them Grant RE39,682 - Kloog June 5, 2 | 2007-06-05 |
| Ras antagonists for treating neurodegenerative disorders App 20070054886 - Kloog; Yoel ; et al. | 2007-03-08 |
| Treatment of post-angioplasty restenosis and atherosclerosis with Ras antagonists Grant 6,946,485 - Kloog , et al. September 20, 2 | 2005-09-20 |
| Non-malignant disease treatment with Ras antagonists App 20050119237 - Kloog, Yoel ; et al. | 2005-06-02 |
| Isoprenoid-dependent ras anchorage (idra) proteins App 20040072258 - Kloog, Yoel ; et al. | 2004-04-15 |
| Treatment of post-angioplasty restenosis and atherosclerosis with Ras antagonists App 20030203942 - Kloog, Yoel ; et al. | 2003-10-30 |
| Non-malignant disease treatment with Ras antagonists Grant 6,462,086 - Kloog , et al. October 8, 2 | 2002-10-08 |
| Treatment of post-angioplasty restenosis and atherosclerosis with ras antagonists App 20020115696 - Kloog, Yoel ; et al. | 2002-08-22 |
| Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions Grant 6,096,740 - Mechoulam , et al. August 1, 2 | 2000-08-01 |
| Farnesyl derivatives and pharmaceutical compositions containing them Grant 5,705,528 - Kloog January 6, 1 | 1998-01-06 |
| NMDA-blocking pharmaceuticals Grant 5,521,215 - Mechoulam , et al. | 1996-05-28 |
| NMDA-blocking pharmaceutical compositions Grant 5,284,867 - Kloog , et al. Fe | 1994-02-08 |
| Drug system Grant 4,994,446 - Sokolovsky , et al. February 19, 1 | 1991-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 